Vector

In-house viral and plasmid stocks ready the next day

About the Vector Core

The Vector Core produces biological products (gene transfer vectors) that facilitate the transfer of specific genes into either normal or aberrant cells. The Vector Core also provides intellectual and technical advice to researchers regarding the optimal use of these systems. Gene transfer vectors require special handling precautions, and manufacturing systems that lend themselves to a core structure that optimizes efficiencies of scale and cost to the research community. The specific objectives of the Vector Core are to:

 

  1. Provide a Core laboratory for the construction, purification, and characterization of recombinant vectors containing genes relevant to the study of disease models for use as in vitro and in vivo gene transfer reagents. These systems include both non-viral (expression plasmid) and viral (recombinant lentivirus, recombinant retrovirus, and recombinant adenovirus) technologies;
  2. Collaborate closely with researchers to ensure the Vector Core provides the platforms our customers require, and to institute the use of new technologies;
  3. Maintain qualified staff and provide high quality, cost-effective products to our researchers.

Process

p

Getting Started

To begin work with the Vector Core, you will first need to register with MiCores and complete training. Please see the Training page for more information on how to get started.

Consultation

For questions regarding your specific needs or project goals please contact Vector Core Director, Tom Lanigan, to set up a consultation.

l

Ordering

Please visit the Products & Services page for more detailed information on what we offer. To request products and services, login to MiCores.

Vector Core by the Numbers

Principal Investigators Worked With (FY18)

Grants Serviced (FY18)

Founded

Events

  • Researchpalooza 2019

    Mark your calendars for the return of Researchpalooza! Join the BRCF and the UMMS Office of Research for Researchpalooza during the annual Michigan Medicine Ice Cream Social, with 80+ exhibitors from labs and offices of the Medical School and across …

     

News

  • DNA Sequencing Core Decommissioning the HiSeq4000

    In order to focus on new and emerging technologies, the DNA Sequencing Core will be discontinuing HiSeq4000 services on June 15, 2019. Samples requiring HiSeq4000 sequencing should be submitted as soon as possible to ensure adequate time for processing prior …

       
  • In Focus: Using Single Cell Analysis to Study the Role of Immune Cells in Bone Regeneration

    Dr. Benjamin Levi Single cell analysis–studying genomics at the level of a single cell–has been an important tool for researchers like Benjamin Levi, MD–Assistant Professor in the Department of Plastic Surgery and Director of the Burn/Trauma and Regenerative Medicine Laboratory. …